Orally bioavailable BTK PROTAC active against wild-type and C481 mutant BTKs in human lymphoma CDX mouse models
口服生物可利用的 BTK PROTAC 对人类淋巴瘤 CDX 小鼠模型中的野生型和 C481 突变型 BTK 具有活性
期刊:Blood Advances
影响因子:7.4
doi:10.1182/bloodadvances.2022008121
Ye Seul Lim, Sun-Mi Yoo, Vineet Patil, Han Wool Kim, Hyun-Hwi Kim, Beomseon Suh, Ji Youn Park, Na-Rae Jeong, Chi Hoon Park, Je Ho Ryu, Byung-Hoon Lee, Pilho Kim, Song Hee Lee
